1. Successive infusions of SQ 20 881 given intra-arterially (i.a.) to the kidney at 0.4 and 0.8 μg min−1 kg−1 for 50 min each did not alter renal blood flow and renal vascular resistance in spite of 40–47% blockade of the angiotensin I (ANG I i.a.)-induced vasoconstrictor response.

2. SQ 20 881 administered intravenously (i.v., 0.5 mg/kg) after the higher intra-arterial dose did not further decrease the renal response to ANG I (i.a.), but caused an increase in renal blood flow and a decrease in renal vascular resistance.

3. These results indicate that SQ 20 881 has limited efficacy in blocking the renal response to ANG I (i.a.). Under the conditions of these experiments, the renal vasodilator response to SQ 20 881 appears to be due to inhibition of extrarenal rather than intrarenal converting enzyme.

This content is only available as a PDF.
You do not currently have access to this content.